An observational study in Falls, sponsored by BioSensics. Completed at 1 site in United States. Open to participants aged 75 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-07-24.
Sponsored by BioSensics · Observational
Medical alert devices with automatic fall detection functionality use accelerometry to detect a fall and can signal for help if the wearer forgets to, or is incapable of, pressing the alert button. This can save lives and prevent complications associated with long periods of time spent on the floor after a fall. In this project, the sensitivity and false alarm rate of a commercially available medical alert device will be tested in a population of 200 community-dwelling older adults.
BioSensics is the lead sponsor of 12 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Older adult study participants will be recruited from the cohort of participants in the STRIDE Study at the Boston trial site (http://www.stride-study.org/).
Exclusion Criteria:
Older adult study participants will be recruited from the cohort of participants in the STRIDE Study at the Boston trial site (http://www.stride-study.org/).
Other: Fall Detection
All participants will wear a device configured to detect falls.
Also known as: ActivePERS
The sensitivity and specificity of ActivePERS fall detection algorithms will be measured by comparing the occurence of falls detected by the wearable device to study participant self reported falls
Time frame: 2 years
Near falls as measured by patient self report
Time frame: 2 years
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
BioSensics